The bizarre thing is that it still doesn't seem to have been "published" yet, so it is still open to being changed - - I get access to a number of papers this way with this understanding. When it is copyright then usually resides with the publisher not the author.
In any event I go back to the question of what is meant by "used as a screening measure" - - something Finkelhor himself isn't clear about. There's a world of difference between my using the ACEsQ as a clinician, with my knowledge and experience, and it being used as something like a chest X-ray for TB but without "medical" review. In the former case I can build into my practice things which would be much more difficult than in the latter; and it is in the latter cases that his cautions are most valid.
In the end the basic rules apply: people shouldn't rush into using any clinical measure without proper prior knowledge of its limitations. Perhaps before the article is actually printed this could be made plain: Jane Stevens and others on this forum have said much about what cautions need to be in place for it to be used effectively.